IDCR, a forum for correctional problem solving,
targets correctional administrators and HIV/AIDS and hepatitis care
providers including physicians, nurses, outreach workers, and case
managers. Continuing Medical Education credits are provided by Nova Southeastern University Health Professions Division (NSU) to physicians who accurately respond to the questions on the last page of the newsletter.
The
editorial board and contributors to IDCR include national and regional
correctional professionals, selected on the basis of their experience
with HIV and hepatitis care in the correctional setting and their
familiarity with current HIV and hepatitis treatment. We encourage
submissions, feedback, and correspondence from our readership.
IMPORTANT INFORMATION
Over the past 10 years IDCR has strived to bring you the most up-to-date, relevant information on managing infectious diseases in the correctional setting. As we celebrate a decade of publication, we would like to personally thank you for your continued support and engagement. Unfortunately, this will be IDCR’s last issue as an independent publication. While it is our every intention to continuing publishing issues under a new umbrella organization, these plans have yet to be determined. Please read the letter from the editor to learn more.
Important Things to Know:
• Continuing medical education credit will continue to be available through August 2009. Please refer to the instructions and expiration date of the issue when applying for credit.
• All of our issues (February 1999-July/August 2008) will be available online at www.IDCROnline.org through 2014. Click on the Archives link at the top of the web page for a complete list of archived issues.
We have made these arrangements to allow maximum access to IDCR content during this time of uncertainty.
We apologize for any confusion or inconvenience these changes may cause. If you have any questions feel free to contact me at (401)453-2068 or idcrme@gmail.com
ABOUT THIS CONTINUING EDUCATION ACTIVITY
NSU designates this educational activity
for a maximum of 1 AMA PRA Category 1 Credit(s)T. Physicians should
only claim credit commensurate with the extent of their participation
in the activity. Statements of credit will be mailed within 6 to 8
weeks following the program.
To obtain credit read the Main Article, Spotlight and 101 sections of the monograph. When completed with both items download the PDF version ( click here to download free adobe reader) | (System requirements) of the monograph located on the sidebar and complete the post test, credit application and evaluation form at the end of the monograph. You must receive a test score of at least 75% and respond to all evaluation questions to receive a certificate. To receive your certificate mail or fax the post test, credit application and evaluation to:
IDCR
146 Clifford Street
Providence, RI 02903
or fax it to (401)272-7562
The material presented in this activity does not reflect the views of NSU. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. NSU and IDCR do not recommend the use of any product outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
Release Date: 7-1-08
End Date: 8-30-09
|
COMMERCIAL SUPPORTERS
OBJECTIVES
- The learner will be able to explain the different types of FDA-approved rapid HIV tests, how they are used, and details
related to their sensitivity and specificity.
- The learner will be able to discuss how to communicate rapid HIV test results and how to incorporate HIV counseling with the rapid testing process.
- The learner will be able to describe recent studies related to feasibility and cost analysis of rapid testing in jails.
|
PURPOSE STATEMENT AND TARGET AUDIENCE
The purpose of this monograph is to increase the knowledge of correctional health care providers on FDA-approved rapid HIV tests, communicating results offering HIV counseling for rapid testing, and on the benefits of implementing a rapid HIV testing program in a jail setting.
|
DISCLOSURES
Faculty Disclosure
NSU have no financial relationships to disclose.
In accordance with the Accreditation Council for NSU, the faculty for this
activity has been asked to complete Conflict of Interest Disclosure
forms. |
|
Executive Editor
Anne S. De Groot, MD
Adjunct Associate Professor
Warren Alpert School of Medicine of Brown University
Nothing to Disclose
Editor in Chief
Joseph Bick, MD
Chief Deputy, Clinical Services California Medical Facility
California Department of Corrections
Nothing to Disclose
Deputy Editor
David Alain Wohl, MD
Associate Professor of Medicine
Division of Infectious Diseases
AIDS Clinical Research Unit
The University of North Carolina- Chapel Hill
Disclosures: Speaker: Abbott Laboraties, Gilead Sciences, Inc., Tibotec Therapeutics, Roche Pharmaceuticals, Merck & Co.,
Boehringer-Ingelheim, Bristol-Myers Sqibb.
Renee Ridzon, MD
Senior Program Officer
HIV, TB, Reproductive Health
Bill & Melinda Gates Foundation
Nothing to Disclose
|
|
Brooke E. Hoots, MSPH
The University of North Carolina School of Public Health
Disclosures: Nothing to disclose
David A. Wohl, MD
Associate Professor of Medicine
University of North Carolina
AIDS Clinical Research Unit
Disclosures: See above
|
|